CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 58 filers reported holding CLEARSIDE BIOMEDICAL INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $80,000 | +29.0% | 58,115 | 0.0% | 0.00% | – |
| Q4 2018 | $62,000 | -89.8% | 58,115 | -41.3% | 0.00% | – |
| Q3 2018 | $608,000 | +13.9% | 98,946 | +98.1% | 0.00% | -100.0% |
| Q2 2018 | $534,000 | +23.9% | 49,936 | +24.3% | 0.00% | 0.0% |
| Q1 2018 | $431,000 | +53.4% | 40,163 | 0.0% | 0.00% | – |
| Q4 2017 | $281,000 | -12.5% | 40,163 | +9.3% | 0.00% | – |
| Q3 2017 | $321,000 | -4.2% | 36,730 | 0.0% | 0.00% | – |
| Q2 2017 | $335,000 | +159.7% | 36,730 | +126.3% | 0.00% | – |
| Q1 2017 | $129,000 | +12.2% | 16,230 | +25.6% | 0.00% | – |
| Q4 2016 | $115,000 | -24.3% | 12,918 | +47.9% | 0.00% | – |
| Q3 2016 | $152,000 | – | 8,737 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 2,462,500 | $11,993,000 | 6.16% |
| ACUTA CAPITAL PARTNERS, LLC | 1,316,268 | $6,410,000 | 2.56% |
| AJU IB Investment Co., Ltd. | 293,555 | $1,430,000 | 0.82% |
| RTW INVESTMENTS, LP | 4,206,765 | $20,487,000 | 0.31% |
| Carmignac Gestion | 3,419,877 | $16,655,000 | 0.19% |
| EAM Investors, LLC | 247,561 | $1,206,000 | 0.19% |
| Curi Wealth Management, LLC | 25,000 | $121,000 | 0.06% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 316,600 | $1,542,000 | 0.03% |
| TWO SIGMA ADVISERS, LP | 990,000 | $4,821,000 | 0.01% |
| CAXTON ASSOCIATES LP | 24,677 | $120,000 | 0.01% |